ID: ALA482622

Max Phase: Preclinical

Molecular Formula: C26H30N6O

Molecular Weight: 442.57

Molecule Type: Small molecule

Representations

Canonical SMILES:  c1ccc2c(c1)OCCc1c-2n(CCc2nnnn2CCN2CCCCC2)c2ccccc12

Standard InChI:  InChI=1S/C26H30N6O/c1-6-14-30(15-7-1)17-18-32-25(27-28-29-32)12-16-31-23-10-4-2-8-20(23)21-13-19-33-24-11-5-3-9-22(24)26(21)31/h2-5,8-11H,1,6-7,12-19H2

Standard InChI Key:  FWCCYKPWEXQGON-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 442.57

Molecular Weight (Monoisotopic): 442.2481

AlogP: 3.96

#Rotatable Bonds: 6

Polar Surface Area: 61.00

Molecular Species: BASE

HBA: 7

HBD: 0

#RO5 Violations: 0

HBA (Lipinski): 7

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 8.56

CX LogP: 4.03

CX LogD: 2.84

Aromatic Rings: 4

Heavy Atoms: 33

QED Weighted: 0.45

Np Likeness Score: -1.39

References

1. Singh US, Shankar R, Yadav GP, Kharkwal G, Dwivedi A, Keshri G, Singh MM, Moulik PR, Hajela K..  (2008)  Synthesis and structure guided evaluation of estrogen agonist and antagonist activities of some new tetrazolyl indole derivatives.,  43  (10): [PMID:18155810] [10.1016/j.ejmech.2007.10.035]

Source

Source(1):

• Scientific Literature